Photo from wikipedia
Bladder cancer is frequently encountered in kidney-recipients and its treatment can be challenging. In fact, it is not known whether adjuvant intravesical Bacillus Calmette-Guerin (BCG) instillation may be as effective… Click to show full abstract
Bladder cancer is frequently encountered in kidney-recipients and its treatment can be challenging. In fact, it is not known whether adjuvant intravesical Bacillus Calmette-Guerin (BCG) instillation may be as effective and safe as in non-immunosuppressed patient. In this letter, we reported results from all studies available to date on BCG treatment in kidney recipients, to discuss safety and efficacy of this treatment modality, in this special population with an altered immune response.
Keywords:
bladder cancer;
safety efficacy;
bacillus calmette;
calmette guerin;
kidney
Journal Title: Clinical Transplantation
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical Transplantation
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!